WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL

Spremljeno u:
Bibliografski detalji
Glavni autori: Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Jonathan Barratt
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2024-04-01
Serija:Kidney International Reports
Online pristup:http://www.sciencedirect.com/science/article/pii/S2468024924004455
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items